Aclarion, INC 10-K annual reports

Annual reports — audited financials, the full risk-factor list, and management’s account of the year.

NASDAQ
Aclarion's 2024 10-K filing highlights its ongoing efforts to commercialize its NOCISCAN technology, secure payer contracts, and expand strategic relationships within the low back pain market.
NASDAQ
Aclarion, Inc. released its 10-K filing for fiscal year 2023, detailing its financial performance, strategic initiatives, and future outlook in the healthcare technology sector.